Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Interest & Investment Income (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Interest & Investment Income for 6 consecutive years, with $580000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 36.47% year-over-year to $580000.0, compared with a TTM value of $2.2 million through Dec 2025, down 56.73%, and an annual FY2025 reading of $2.2 million, down 56.73% over the prior year.
  • Interest & Investment Income was $580000.0 for Q4 2025 at Cytek Biosciences, up from $573000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.6 million in Q4 2022 and bottomed at $9000.0 in Q2 2021.
  • Average Interest & Investment Income over 5 years is $920950.0, with a median of $746500.0 recorded in 2024.
  • The sharpest move saw Interest & Investment Income surged 14488.89% in 2022, then plummeted 62.62% in 2025.
  • Year by year, Interest & Investment Income stood at $18000.0 in 2021, then soared by 14488.89% to $2.6 million in 2022, then plummeted by 44.86% to $1.4 million in 2023, then plummeted by 36.95% to $913000.0 in 2024, then plummeted by 36.47% to $580000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for CTKB at $580000.0 in Q4 2025, $573000.0 in Q3 2025, and $555000.0 in Q2 2025.